These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22844497)

  • 41. Novel type III effectors in Pseudomonas aeruginosa.
    Burstein D; Satanower S; Simovitch M; Belnik Y; Zehavi M; Yerushalmi G; Ben-Aroya S; Pupko T; Banin E
    mBio; 2015 Mar; 6(2):e00161. PubMed ID: 25784698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural basis of chaperone recognition of type III secretion system minor translocator proteins.
    Job V; Matteï PJ; Lemaire D; Attree I; Dessen A
    J Biol Chem; 2010 Jul; 285(30):23224-32. PubMed ID: 20385547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ubiquitin ligase Cbl-b limits Pseudomonas aeruginosa exotoxin T-mediated virulence.
    Balachandran P; Dragone L; Garrity-Ryan L; Lemus A; Weiss A; Engel J
    J Clin Invest; 2007 Feb; 117(2):419-27. PubMed ID: 17235393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome.
    Sutterwala FS; Mijares LA; Li L; Ogura Y; Kazmierczak BI; Flavell RA
    J Exp Med; 2007 Dec; 204(13):3235-45. PubMed ID: 18070936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Primed Subpopulation of Bacteria Enables Rapid Expression of the Type 3 Secretion System in Pseudomonas aeruginosa.
    Lin CK; Lee DSW; McKeithen-Mead S; Emonet T; Kazmierczak B
    mBio; 2021 Jun; 12(3):e0083121. PubMed ID: 34154400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of antimicrobial peptides in corneal infection and regulation of antimicrobial peptides and reactive oxygen species by type III secretion system of Pseudomonas aeruginosa.
    Sharma P; Guha S; Garg P; Roy S
    Pathog Dis; 2018 Feb; 76(1):. PubMed ID: 29325116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudomonas aeruginosa Can Diversify after Host Cell Invasion to Establish Multiple Intracellular Niches.
    Kumar NG; Nieto V; Kroken AR; Jedel E; Grosser MR; Hallsten ME; Mettrucio MME; Yahr TL; Evans DJ; Fleiszig SMJ
    mBio; 2022 Dec; 13(6):e0274222. PubMed ID: 36374039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes.
    Goure J; Pastor A; Faudry E; Chabert J; Dessen A; Attree I
    Infect Immun; 2004 Aug; 72(8):4741-50. PubMed ID: 15271936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia.
    Elsen S; Huber P; Bouillot S; Couté Y; Fournier P; Dubois Y; Timsit JF; Maurin M; Attrée I
    Cell Host Microbe; 2014 Feb; 15(2):164-76. PubMed ID: 24528863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ.
    Lilo S; Zheng Y; Bliska JB
    Infect Immun; 2008 Sep; 76(9):3911-23. PubMed ID: 18559430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T3SS effector ExoY reduces inflammasome-related responses by suppressing bacterial motility and delaying activation of NF-κB and caspase-1.
    Jeon J; Kim YJ; Shin H; Ha UH
    FEBS J; 2017 Oct; 284(20):3392-3403. PubMed ID: 28815941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection.
    Berube BJ; Murphy KR; Torhan MC; Bowlin NO; Williams JD; Bowlin TL; Moir DT; Hauser AR
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807906
    [No Abstract]   [Full Text] [Related]  

  • 54. Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.
    Anderson DM; Schmalzer KM; Sato H; Casey M; Terhune SS; Haas AL; Feix JB; Frank DW
    Mol Microbiol; 2011 Dec; 82(6):1454-67. PubMed ID: 22040088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Atypical Response Regulator AtvR Is a New Player in Pseudomonas aeruginosa Response to Hypoxia and Virulence.
    Kaihami GH; Breda LCD; de Almeida JRF; de Oliveira Pereira T; Nicastro GG; Boechat AL; de Almeida SR; Baldini RL
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28533471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo.
    Allen L; Dockrell DH; Pattery T; Lee DG; Cornelis P; Hellewell PG; Whyte MK
    J Immunol; 2005 Mar; 174(6):3643-9. PubMed ID: 15749902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pseudomonas aeruginosa activates caspase 1 through Ipaf.
    Miao EA; Ernst RK; Dors M; Mao DP; Aderem A
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2562-7. PubMed ID: 18256184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A.
    Kuang Z; Hao Y; Walling BE; Jeffries JL; Ohman DE; Lau GW
    PLoS One; 2011; 6(11):e27091. PubMed ID: 22069491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection.
    Wu H; Song Z; Givskov M; Doring G; Worlitzsch D; Mathee K; Rygaard J; Høiby N
    Microbiology (Reading); 2001 May; 147(Pt 5):1105-1113. PubMed ID: 11320114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oligoribonuclease is required for the type III secretion system and pathogenesis of Pseudomonas aeruginosa.
    Chen G; Zhao Q; Zhu F; Chen R; Jin Y; Liu C; Pan X; Jin S; Wu W; Cheng Z
    Microbiol Res; 2016; 188-189():90-96. PubMed ID: 27296966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.